Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Top Headlines

Samsung BioLogics opens third plant, contemplates a fourth in Korea

The CDMO’s third biomanufacturing plant, regarded the world’s largest, is now operational in South Korea.

Be the Match partners to improve traceability of cell and gene therapies

Be the Match and Cryoport have collaborated to enhance supply chain services in the cell and therapy industry.

Mammalian plant a convenient option for growing Asian client base, says AGC

AGC Biologics has announced plans to build a mammalian cell culture facility in Japan, where the company says demand is growing for antibody-based therapies.

Merck biosimilar made available on the US VA National Formulary

The US Department of Veteran Affairs awarded a national contract for Merck’s biosimilar to be available on its National Formulary.

Gilead seals UK deal for Yescarta to treat patients by end of year

NHS England has approved CAR-T therapy Yescarta, placing Gilead one-step ahead of Novartis in the race to treat UK adult patients.

Global Industry News

Hot Topics

Spotlight

Plant-based expression system produces higher yields than mammalian alternatives, says CEO

Genetic disease drugmakers should sponsor at-home genetic tests, advises consultant

Collaboration to enhance gene therapy logistics in Japan’s growing market

Datwyler opens first US production plant, boosting output by 50%

Products

Webinars

On-demand webinars

Marken: Global Life Science Supply Chain Solutions Exploring the value of home visits in clinical trials, the benefits gained by both the patient and the sponsor

Featured Suppliers

All suppliers

Baxter BioPharma Solutions

Bio-Rad Laboratories

Marken: Global Life Science Supply Chain Solutions

Merck KGaA, Darmstadt, Germany

Samsung BioLogics